Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy.

Journal of the National Cancer Institute - 1 Feb 2018

Saule Claire, Mouret-Fourme Emmanuelle, Briaux Adrien, Becette Véronique, Rouzier Roman, Houdayer Claude, Stoppa-Lyonnet Dominique

Abstract excerpt

It has recently been shown that the risk of a rare subtype of endometrial carcinoma (serous type) in women carrying a germline BRCA1/2 pathogenic variant is increased. We assessed the incidence of serous endometrial carcinoma in an independent prospective cohort study of 369 BRCA1/2 women (1779 woman-years of follow-up) who underwent risk-reducing salpingo-oophorectomy by laparoscopy. This occurrence in two BRCA1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystadenocarcinoma, Serous

Share to Endometrial Neoplasms

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Ovariectomy

Share to Salpingectomy

Source

Identifiers

PMID: 28954295
DOI: 10.1093/jnci/djx159

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy.PMID 28954295Read ↗

Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers.Semantic proximity Read ↗

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.Semantic proximity Read ↗

BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study.Semantic proximity Read ↗

Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesions.Semantic proximity Read ↗

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Endometrial Cancer in Germline BRCA Mutation Carriers: A Systematic Review and Meta-analysis.Semantic proximity Read ↗

Risk of endometrial cancer after RRSO in BRCA 1/2 carriers: a multicentre cohort study.Semantic proximity Read ↗

Retrospective evaluation of risk-reducing salpingo-oophorectomy for BRCA1/2 pathogenic variant carriers among a cohort study in a single institution.Semantic proximity Read ↗

Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.Semantic proximity Read ↗

Hereditary Women's Cancer: Management and Risk-Reducing Surgery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.